Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G(2)/M transition by controlling the expression of p21(Waf1/Cip1) (p21), which is believed to regulate cyclin B-Cdc2 kinase activity ...
in G(2). In growing myoblasts, MyoD reaccumulates during G(2) concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G(2) and delays M-phase entry. This G(2) arrest is not observed in p21(-/-) cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G(2)/M transition.
Mesh Terms:
Animals, CDC2 Protein Kinase, Cell Line, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclins, G2 Phase, Gene Expression Regulation, Histone Deacetylase 1, Histone Deacetylases, Mice, Mitosis, Models, Biological, Muscle, Skeletal, Mutation, MyoD Protein, Myoblasts, Phosphorylation, Phosphoserine, Protein Binding, Time Factors, Transcriptional Activation
Mol. Cell. Biol.
Date: Feb. 01, 2004
Download Curated Data For This Publication
114424
Switch View:
  • Interactions 6